Medication Side Effects!
Question:
I am going through the same thing with my pills, weight gain bothers me so much that im willing to risk my stability for it. Although Im on a different med than your husband im having the same problem. I switched to a similar drug without the weight gain side effects, The weight gain problem is gone but Im not functioning well at all. Kisha
Response:
Hi Francine, i’ve been on lithium and effexor for 6 months now and i’ve gained 40 + lbs. i keep telling my dr. that i want to get on something else cause i have grown out of all my clothes ad i eel more depressed than ever. she put me on topamaxx which has the opposite effect as far as hunger goes. i didn’t do well on it but that is not to say that others wouldn’t do better. it is relatively new and it might be worth try.
Unfortunately, many people complain of weight gain while taking psychoactive drugs. I have included a post I had authored on this topic. I hope it is helpful. Please email me anytime. Peace, Lynda Prudent Eating Plan for Improved Well-Being By Lynda F. Cunningham, MSN, MA, A&GNP-C, CNS, RNC Adult and Geriatric Nurse Practitioner Clinical Nurse Specialist Exercise Physiologist Eliminate or cut down on refined carbohydrates (sugar, candy, cakes, cookies). Eat complex carbohydrates found in vegetables, beans and grains,and fruits…55% of diet calories should include complex carbohydrates which are high in fiber. Protein intake: Limit protein to less than 15% of your total calories ( 50 grams for females -60 grams for males daily). Limit the intake of red meat. Remove skin from poultry before cooking. Avoid frying. Substitute: baking, broiling, boiling, or microwaving. Too much protein can: Overwork the kidneys (nitrogenous wastes). Interfere with the absorption of certain minerals such as calcium and may cause the excretion of certain mineral in the urine. Saturated fats (fried foods, lard, butter, etc.) bacon, snacks like potato chips…pretzels are fine as are peanuts but be careful of the amount you eat because they can be fattening) Saturated fats contribute to obesity, atherosclerosis, angina, some types of cancer (colon), diabetes from an overworked pancreas, and fatigue. Eat polyunsaturated and monosaturated fats…limit intake to 30% or less of total calories. These are found in plants and fish. Omega-3 fatty acids may help lower blood cholesterol levels and prevent heart attacks. They are now being used to treat Bipolar Illness. Linoleic acid (a polyunsaturated fatty acid) is an essential fatty acid that must be gotten from foods. It is found in vegetable oils, raw nuts, seeds, legumes, and in unsaturatedvegetable oils, such a borage oil, grape seed oil, primrose oil, sesame oil, and soybean oil.. It is important for growth and development as well as the production of hormone like substances (prostaglandins) that act as chemical messengers and regulators of various body processes. Omega 3 fatty acids (alpha-linoleic and eicosapentaenoic(EPA) are found in freshwater fish, fish oil, canola oil, walnut oil, and flaxseed oil. Consume these oils in pure liquid form or supplement form. Do NOT subject them to heat, either in processing or cooking as heat destroys essential fatty acids. If oils are hydrogenated (processed to make an oil more solid as in margarine) the linoleic acid is converted into trans-fatty acids which are not beneficial to the body. Eat 6 small meals daily instead of 3 large ones. This will keep your blood glucose steady instead of the peaks and valleys that can occur with eating only 3 times a day Limit caffeine intake including coffee, non herbal teas, sodas. CONSULT with your physician before taking any: Vitamin Supplements Homeopathic Preparations Herbal Supplements Amino Acids Suggested supplements after checking with your Physician, Nurse Practitioner, or Physician Assistant: Take a mutivitamin and mineral supplement as well as a B complex vitamin (50-100 mg) daily Extra vitamin C…1000-5000 mg depending on your nicotine intake. If you smoke each cigarette destroys anywhere from 25-75 mg of vitamin C Flaxseed oil…10 grams daily (it has to be refrigerated) do not use the capsules Calcium 1200-1500 mg/day Magnesium 600-750 mg/day Selenium 50-100 mcg/day VitaminE 400-800 IU/day Zinc 50 mg/day Exercise daily for at least 30 minutes. Start low and go slow!!! Aerobic exercises include non stop activities such as: Walking briskly Treadmill Walking Cycling Jogging Stairmaster Elliptical Cross Trainer Swimming Laps Water Aerobics Water Jogging Aerobic Dancing Step Aerobics Low Impact Aerobics Box Aerobics Funk/Jam Aerobics For weight loss, exercise 5 days a week at 60-85% of maximum heart rate-MHR ( 220-your age=MHR, then multiply by 60% and 85% . That is your target heart rate range(THR). Exercise for a minmum of 30 minutes as fat catabolism begins at 20 minutes into exercise. Aim for 45 minutes. If you go above your target heart range you are working anerobically and thus are burning carbohydrates not fat. Any excess carbohydrates or protein will be converted to fat. *****Fat is burned in the mitochondria of the muscles. So the more muscle mass you have, the more efficient you are at burning fat.**** Therfore add weight training to your program at least 2 times a week, preferably 3 times a week. {Copyright 1999: All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means , electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the copyright owner} References: Food and Nutrition edited by John Feltman (1993) Griffin’s 5 Minute Clinical Consult by Mark R. Dambro M.D., FAAFP (1997) Nutrition in Clinical Nursing by Idamarie LaQuatra, Ph.D., R.D. and Mary Jo Gerlach, R.N., M.S.N.Ed. (1990) Pathophysiology: The Biologic Basis for Disease in Adults and Children, by Kathryn L. McCance R.N., Ph.D and Sue E. Huether, R,N., Ph.D (1994) Prescription for Nutrition and Healing by James L. Balch, M.D. and Phyllis Balch, C.N.C.<Certified Nutrion Consultant (1997) Understanding Normal and Clinical Nutrition by Eleanor Noss Whitney, Ph.D, R.D., Corinne Balog Cataldo, M.M.Sc.,R.D, L.D., C.N.S.D.and Sharon Rady Rolfes, M.S., R.D (1991) The Washington Manual of Medical Therapeutics, Editors: Charles F. Carey, M.D., Keith F. Woeltje, M.D., Ph.D., Hans H.Lee, M.D., Robyn A. Schaiff, Pharm.D (1998)
Response:
i’ve been on lithium and effexor for 6 months now and i’ve gained 40 + lbs. i keep telling my dr. that i want to get on something else cause i have grown out of all my clothes ad i eel more depressed than ever. she put me on topamaxx which has the opposite effect as far as hunger goes. i didn’t do well on it but that is not to say that others wouldn’t do better. it is relatively new and it might be worth try.
Response:
Hi marie, My husband has more than rapid cycling BP. He is on Lithium and Paxil but has gained 30 pounds in 2 months. (this only bothers him) He also has a rash that was worse on Prozac. He is not taking his meds regularly due to these side effects and has 1-2 great mood days ands 1-2 depressed days then 1-2 manic days. any ideas?
Prozac and Paxil can cause a rash and itchiness. Weight gain is common on Lithium for some people. It sounds like he does have RC…perhaps a discussion with his pdoc ,of other med options, such as Lamictal, may be helpful. I have included info on Lamictal for you all to read. Peace, Lynda This is an example of the info that can be quickly and easily accessed from Dr. Goldberg’s site. LAMICTAL: B.W. Inc.Lamotrigine Antiepileptic Pharmacology: Lamotrigine is a drug of the phenyltriazine class chemically unrelated to existing antiepileptic drugs (AEDs). Lamotrigine is thought to act at voltage-sensitive sodium channels to stabilize neuronal membranes and inhibit the release of excitatory amino acid neurotransmitters (e.g. glutamate, aspartate) that are thought to play a role in the generation and spread of epileptic seizures. Clinical Trials: In placebo-controlled clinical studies, lamotrigine has been shown to be effective in reducing seizure frequency and the number of days with seizures when added to existing antiepileptic drug therapy in adult patients with partial seizures, with or without generalized tonic-clonic seizures, that are not satisfactorily controlled. Pharmacokinetics: Adults: Lamotrigine is rapidly and completely absorbed following oral administration, reaching peak plasma concentrations 1.4 to 4.8 hours (Tmax) post-dosing. When administered with food, the rate of absorption is slightly reduced, but the extent remains unchanged. Following single lamotrigine doses of 50 to 400 mg, peak plasma concentration (Cmax=0.6-4.6ug/mL) and the area under the plasma concentration-versus-time curve(AUC=29.9-211 hug/mL) increase linearly with dose. The time-to-peak concentration, eliminatio half-life (t1/2) and volume of distribution (Vd/F) are independent of dose. The t1/2 averages 33 hours after single dose and Vd/F ranges from 0.9 to 1.4 L/kg. Following repeated dosing of healthy volunteers for 14 days, the t1/2 decreased by an average of 26% (mean steady state t1/2 of 26.4 hours) and plasma clearance increased by an average of 33%. In a single-dose study where healthy volunteers were administered both oral and i.v. doses of lamotrigine, the absolute bioavailability of oral lamotrigine was 98%. Lamotrigine is approximately 55% bound to human plasma proteins. This binding is unaffected by therapeutic concentrations of phenytoin, phenobarbital or valproic acid. Lamotrigine does not displace other antiepileptic drugs (carbamazepine, phenytoin, phenobarbital) from protein binding sites. Lamotrigine is metabolized predominantly in the liver by glucuronic acid conjugation. The major metabolite is an inactive 2-N-glucuronide conjugate that can be hydrolyzed by b-glucuronidase. Approximately 70% of an oral lamotrigine dose is recovered in urine as this metabolite. Geriatrics: The pharmacokinetics of lamotrigine in 12 healthy elderly volunteers (65 years) who each received a single oral dose of lamotrigine (150 mg) were not different from those in healthy young volunteers. (However, see Precautions, Geriatrics and Dosage.) Renal Impairment: The pharmacokinetics of a single oral dose of lamotrigine (100 mg) were evaluated in 12 individuals with chronic renal failure (with mean creatinine clearance of 13 mL/min) who were not receiving other antiepileptic drugs. In this study, the elimination half-life of unchanged lamotrigine was prolonged (by an average of 63%) relative to individuals with normal renal function (see Precautions, Renal Failure and Dosage.) Hemodialysis: In 6 hemodialysis patients, the elimination half-life of unchanged lamotrigine was doubled off dialysis, and reduced by 50% on dialysis, relative to individuals with normal renal function. Hepatic Impairment: The pharmacokinetics of lamotrigine in patients with impaired liver function has not been evaluated. Gilbert’s Syndrome: Gilbert’s syndrome (idiopathic unconjugated hyperbilirubinemia) does not appear to affect the pharmacokinetic profile of lamotrigine. Concomitant Antiepileptic Drugs: In patients with epilepsy, concomitant administration of lamotrigine with enzyme-inducing AEDs (phenytoin, carbamazepine, primidone or phenobarbital) decreases the mean lamotrigine t1/2 to 13 hours. Concomitant administration of lamotrigine with valproic acid significantly increases t1/2 and decreases the clearance of lamotrigine, whereas concomitant administration of lamotrigine with valproic acid plus enzyme-inducing AEDs can prolong t1/2 up to approximately 27 hours. Acetaminophen was shown to slightly decrease the t1/2 and increase the clearance of lamotrigine. The key lamotrigine parameters for adult patients and healthy volunteers are summarized in Table I. Indications: As adjunctive therapy for the management of patients with epilepsy who are not satisfactorily controlled by conventional therapy. There is limited information on the use of lamotrigine in monotherapy at this time. Contraindications: Patients with known hypersensitivity to lamotrigine or to any components of the formulation. Warnings: Serious dermatologic events have been reported infrequently in patients receiving lamotrigine. Such events were more likely to occur during the first 6 weeks of therapy. More rapid initial titration dosing and use of concomitant valproic acid were associated with a higher incidence of serious dermatologic events (see Precautions, Skin-Related Events, Table II and Table III; see also Dosage). These events have included Stevens-Johnson syndrome, toxic epidermal necrolysis, angioedema, and hypersensitivitysyndrome (which usually consisted of fever, rash, facial swelling and other systemic involvement, e.g. hematologic, hepatic and/or lymphatic). Hepatic injury, as part of a hypersensitivity syndrome, may have been the initiating event in one reported death. It is recommended that the physician closely monitor (including hepatic, renal and clotting parameters) patients who acutely develop any combination of unexplained rash, fever, flu-like symptoms or worsening of seizure control, especially within the first month of starting treatment. Patients who develop a rash should be promptly evaluated. Lamotrigine should be discontinued in all patients with a medically serious rash. Although many patients who developed a skin rash in clinical trials continued to receive lamotrigine without consequences, the initial presentation of a rash is not always indicative of its eventual seriousness. The potential medical benefits of continued therapy with lamotrigine must be weighed against the increased risk of serious rash in patients who have already developed a rash. Precautions: Drug Discontinuation: Abrupt discontinuation of any antiepileptic drug (AED) in a responsive patient with epilepsy may provoke rebound seizures. In general, withdrawal of an AED should be gradual to minimize this risk. Unless safety concerns require a more rapid withdrawal, the dose of lamotrigine should be tapered over a period of at least 2 weeks (see Dosage). Occupational Hazards: Patients with uncontrolled epilepsy should not drive or handle potentially dangerous machinery. During clinical trials common adverse effects included dizziness, ataxia, drowsiness, diplopia and blurred vision. Patients should be advised to refrain from activities requiring mental alertness or physical coordination until they are sure that lamotrigine does not affect them adversely. Skin-Related Events: In controlled studies of adjunctive lamotrigine therapy, the incidence of rash (usually maculopapular and/or erythematous) in patients receiving lamotrigine was 10% compared with 5% in placebo patients. The rash usually occurred within the first 6 weeks of therapy and resolved during continued administration of lamotrigine. Lamotrigine was discontinued because of rash in 1.1% of patients in controlled studies and 3.8% of all patients in all studies. The rate of rash-relatedwithdrawal in clinical studies was higher with more rapid initial titration dosing, and in patients receiving concomitant valproic acid (VPA), particularly in the absence of enzyme-inducing AEDs (see Table II and Table III; see also Warnings and Dosage). Increased incidence of rash-related withdrawal was seen when initial doses were higher and titration more rapid than recommended under Dosage. Drug Interactions: Antiepileptic Drugs (AEDs): Lamotrigine does not affect the plasma concentrations of concomitantly administered enzyme-inducing AEDs. Antiepileptic drugs that induce hepatic drug-metabolizing enzymes (phenytoin, carbamazepine, phenobarbital, primidone) increase the plasma clearance and reduce the elimination half-life of lamotrigine (see Pharmacology). Valproic acid reduces the plasma clearance and prolongs the elimination half-life of lamotrigine (see Pharmacology). When lamotrigine was administered to 18 healthy volunteers already receiving valproic acid, a modest decrease (25% on average) in the trough steady-state valproic acid plasma concentrations was observed over a 3-week period, followed by stabilization. However, the addition of lamotrigine did not affect the plasma concentration of valproic acid in patients receiving enzyme-inducing AEDs in combination with valproic acid (see Precautions, Skin-Related Events). Oral Contraceptives: In a study of 12 female volunteers, lamotrigine did not affect plasma concentrations of ethinyl estradiol and levonorgestrel following administration of the oral contraceptive pill. However, as with … read more »
Response:
have any women on this list had any side effects relating to their menstrual cycles with any of the mood stabilizers?
Response:
Hi, have any women on this list had any side effects relating to their menstrual cycles with any of the mood stabilizers?
Try: Relationship between BP and hormones: http://www.onhealth.com/ch1/columnist/item,46699.asp Peace, Lynda
Response:
My husband has more than rapid cycling BP. He is on Lithium and Paxil but has gained 30 pounds in 2 months. (this only bothers him) He also has a rash that was worse on Prozac. He is not taking his meds regularly due to these side effects and has 1-2 great mood days ands 1-2 depressed days then 1-2 manic days. any ideas?
– Hide quoted text — Show quoted text – All medications have side effects. Some are harmless while others can cause havoc with one’s liver, kidneys or thyroid gland as well as affect blood sugar. Since medications are a necessary fact of life for people with BP illness, it is up to us and our pdocs to determine which ones are deleterious and which can be managed so the effects are minimized…
Response:
All medications have side effects. Some are harmless while others can cause havoc with one’s liver, kidneys or thyroid gland as well as affect blood sugar. Since medications are a necessary fact of life for people with BP illness, it is up to us and our pdocs to determine which ones are deleterious and which can be managed so the effects are minimized. Your pharmacist is a resource with whom to consult when you are unsure about interactions with other medications, including nonprescription drugs, herbs, vitamins, mineral, and homeopathic remedies. It is also important to let your medical doctor know all the medications you are taking…especially if you are being treated for other comorbid conditions (i.e. hypertension, diabetes). Some drugs should be taken on an empty stomach, while others require food. Many drugs should be taken at set intervals throughout the day (Neurontin every 6 hours) to insure adequate blood levels. Monitoring of drug blood levels for Lithium, Depakote and Tegertol are essential in insuring that a therapeutic level is achieved and maintained. Baseline blood tests done before initiation of treatment include: 1. CBC (complete blood count) 2. Thyroid tests (specifically a TSH level) as well as T3 and T4 3. Renal tests 4. Hormone panel for females 5. Electrolyte, blood lipids (fasting), and glucose (fasting) tests Blood pressure, heart rate, and a baseline EKG are also necessary components of a physical exam before treatment is started. Monitoring of blood levels, renal function and thyroid should be done every 6 months while on Lithium. Depakote and Tegretol levels should be monitored every 6 months. When a dose is changed ,then the level needs to be checked the first week and then in 3 months to insure that a therapeutic level is achieved. The newer medications used as Mood Stabilizers (MS) are Neurontin, Topomax, and Lamictal. At present, no therapeutic levels for BP illness have been established. It appears that polytherapy (combination drug therapy) is more successful in treating refractory or resistant BP illness as well as rapid cycling conditions. Peace, Lynda
Categories:
